The Hippo pathway and human cancer

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nature Reviews. Cancer

• Publication date

  2013-03-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrc3458PMID 23467301
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• POSTER PRESENTATION Open Access

  2013cited by this paper
• Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling.

  2012cited by this paper
• Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis.

  2012cited by this paper
• Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers.

  2012cited by this paper
• Integration of intercellular signaling through the Hippo pathway.

  2012cited by this paper
• The YAP and TAZ transcription co-activators: key downstream effectors of the mammalian Hippo pathway.

  2012cited by this paper
• Homeodomain-interacting protein kinase regulates Hippo pathway-dependent tissue growth.

  2012cited by this paper
• Wnt/β-Catenin Signaling Regulates Yes-associated Protein (YAP) Gene Expression in Colorectal Carcinoma Cells*

  2012cited by this paper
• Chronic inflammation, immune escape, and oncogenesis in the liver: A unique neighborhood for novel intersections

  2012cited by this paper
• Regulation of the Hippo pathway by cell architecture and mechanical signals.

  2012cited by this paper
• Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP.

  2012cited by this paper
• Homeodomain-interacting protein kinase regulates Yorkie activity to promote tissue growth.

  2012cited by this paper
• New frontiers in cell competition †

  2012cited by this paper
• Notch and disease: a growing field.

  2012cited by this paper
• A molecular mechanism that links Hippo signalling to the inhibition of Wnt/β‐catenin signalling

  2012cited by this paper
• Alterations in the Smad pathway in human cancers.

  2012cited by this paper
• Restriction of intestinal stem cell expansion and the regenerative response by YAP

  2012cited by this paper
• Cancer susceptibility and embryonic lethality in Mob1a/1b double-mutant mice.

  2012cited by this paper
• Mammalian sterile 20-like kinase 1 suppresses lymphoma development by promoting faithful chromosome segregation.

  2012cited by this paper
• Targeting the hedgehog pathway: role in cancer and clinical implications of its inhibition.

  2012cited by this paper
• YAP mediates crosstalk between the Hippo and PI(3)K–TOR pathways by suppressing PTEN via miR-29

  2012cited by this paper
• Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.

  2012cited by this paper
• Cancer stem cell definitions and terminology: the devil is in the details

  2012cited by this paper
• LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker

  2012cited by this paper
• Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis

  2012cited by this paper
• Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance

  2011cited by this paper
• Hippo signaling: growth control and beyond

  2011cited by this paper
• Yap 1 Acts Downstream of a-Catenin to Control Epidermal Proliferation

  2011cited by this paper
• Hippo pathway regulation by cell morphology and stress fibers

  2011cited by this paper
• Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma

  2011cited by this paper
• Modulating F‐actin organization induces organ growth by affecting the Hippo pathway

  2011cited by this paper
• A novel WWTR1‐CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites

  2011cited by this paper
• Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila

  2011cited by this paper
• The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.

  2011cited by this paper
• Oncogenic and tumor suppressor functions of Notch in cancer: it’s NOTCH what you think

  2011cited by this paper
• Photodynamic therapy of cancer: An update

  2011cited by this paper
• The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene

  2011cited by this paper
• Phase II Evaluation of Phenoxodiol in Combination With Cisplatin or Paclitaxel in Women With Platinum/Taxane-Refractory/Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers

  2011cited by this paper
• Epithelial cell polarity, stem cells and cancer

  2011cited by this paper
• The Salvador/Warts/Hippo pathway controls regenerative tissue growth in Drosophila melanogaster.

  2011cited by this paper
• E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components

  2011cited by this paper
• A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription.

  2011cited by this paper
• Regulator of G protein signaling proteins as drug targets: current state and future possibilities.

  2011cited by this paper
• Biochemical and structural characterization of lysophosphatidic Acid binding by a humanized monoclonal antibody.

  2011cited by this paper
• Role of YAP/TAZ in mechanotransduction

  2011cited by this paper
• Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors.

  2011cited by this paper
• A kinase shRNA screen links LATS2 and the pRB tumor suppressor.

  2011cited by this paper
• Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size

  2011cited by this paper
• Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma

  2011cited by this paper
• The Hippo–Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis

  2010cited by this paper
• Crumbs regulates Salvador/Warts/Hippo signaling in Drosophila via the FERM-domain protein Expanded.

  2010cited by this paper
• The apical-basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila

  2010cited by this paper
• Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells

  2010cited by this paper
• The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.

  2010cited by this paper
• The Hippo pathway regulates intestinal stem cell proliferation during Drosophila adult midgut regeneration

  2010cited by this paper
• Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms.

  2010cited by this paper
• The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded

  2010cited by this paper
• Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver

  2010cited by this paper
• The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program.

  2010cited by this paper
• Hippo pathway effector Yap is an ovarian cancer oncogene.

  2010cited by this paper
• Diverse somatic mutation patterns and pathway alterations in human cancers.

  2010cited by this paper
• Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression

  2010cited by this paper
• The Hippo pathway regulates Wnt/beta-catenin signaling.

  2010cited by this paper
• Overexpression of yes‐associated protein contributes to progression and poor prognosis of non‐small‐cell lung cancer

  2010cited by this paper
• Tgf-beta signaling alterations and colon cancer.

  2010cited by this paper
• Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver.

  2010cited by this paper
• The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway.

  2010cited by this paper
• Upstream regulation of the hippo size control pathway.

  2010cited by this paper
• The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation.

  2010cited by this paper
• YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation.

  2009cited by this paper
• Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.

  2009cited by this paper
• Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways.

  2009cited by this paper
• Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II]

  2009cited by this paper
• A change of strategy in the war on cancer

  2009cited by this paper
• Wnt/Planar cell polarity signaling: A new paradigm for cancer therapy

  2009cited by this paper
• The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigen

  2009cited by this paper
• YAP: At the crossroad between transformation and tumor suppression

  2009cited by this paper
• The absence of LPA2 attenuates tumor formation in an experimental model of colitis-associated cancer.

  2009cited by this paper
• Yes‐associated protein is an independent prognostic marker in hepatocellular carcinoma

  2009cited by this paper
• A tense situation: forcing tumour progression

  2009cited by this paper
• Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma

  2009cited by this paper
• Matrix crosslinking forces tumor progression by enhancing integrin signaling.

  2009cited by this paper
• Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi

  2008cited by this paper
• Anoikis resistance and tumor metastasis.

  2008cited by this paper
• Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module

  2008cited by this paper
• TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal

  2008cited by this paper
• Basolateral Junctions Utilize Warts Signaling to Control Epithelial-Mesenchymal Transition and Proliferation Crucial For Migration and Invasion of Drosophila Ovarian Epithelial Cells

  2008cited by this paper
• Expression of Yes-associated protein in common solid tumors.

  2008cited by this paper
• Oncogenic mutations in GNAQ occur early in uveal melanoma.

  2008cited by this paper
• Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma

  2007cited by this paper
• Salvador-warts-hippo signaling promotes Drosophila posterior follicle cell maturation downstream of notch.

  2007cited by this paper
• Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression

  2007cited by this paper
• Elucidation of a universal size-control mechanism in Drosophila and mammals.

  2007cited by this paper
• The Salvador–Warts–Hippo pathway — an emerging tumour-suppressor network

  2007cited by this paper
• Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.

  2007cited by this paper
• YAP1 increases organ size and expands undifferentiated progenitor cells.

  2007cited by this paper
• The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway.

  2006cited by this paper
• Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase.

  2006cited by this paper
• A positive feedback loop between the p53 and Lats2 tumor suppressors prevents tetraploidization.

  2006cited by this paper
• Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/Hippo signaling pathway.

  2006cited by this paper

• WGCNA-derived lncRNA MAP3K4-AS1 regulates apoptosis and cell cycle in TNBC MDA-MB-231 cells validated by siRNA knockdown.

  2026cites this paper
• Cytoophidia: Implications and opportunities for cancer treatment.

  2026cites this paper
• Male-biased Yap1-Cd276/B7-H3 axis for immune evasion in medulloblastoma.

  2026cites this paper
• From Signaling Pathways to Combination Therapy: Bioactive Compounds against Cancer Stem Cells

  2026cites this paper
• NF1/2 mutations predict favorable benefit from immune checkpoint inhibitor-based therapies over VEGFR/mTOR inhibitors in clear cell renal cell carcinoma

  2026cites this paper
• Vestigial-like 4 Regulates Neurogenesis and Neural Crest Formation During Xenopus Development.

  2026cites this paper
• Nuclear PD-L1 regulates YAP-driven transcription via the PGE2-EP4-YAP-importin α3 axis in solid tumors.

  2026cites this paper
• The Multi-Faceted Landscape of TEAD Inhibition: a 2017-2025 Patent and Literature Review.

  2026cites this paper
• Curcumin Alleviates Gastric Precancerous Lesions by Modulating YAP/TEAD Signaling Pathway

  2026cites this paper
• Novel insights into the regulation of NF2/SWH signaling in granulosa cells of prehierarchical follicle development in hen ovary

  2026cites this paper
• Distinct molecular pathways leading to dosage-dependent temozolomide resistance in GBM stem cells.

  2026cites this paper
• Analysis of the assembly, stabilization and maturation of the multiphasic TAZ biomolecular condensates

  2026cites this paper
• RNF19A facilitates gastric cancer progression by regulating the Hippo/YAP axis.

  2026cites this paper
• Post-translational modifications in ferroptosis: mechanisms and therapeutic potential

  2026cites this paper
• Targeting Hippo-YAP/TAZ signaling pathway: an updated review demonstrating the therapeutic potential of key plant derived anticancer compounds

  2026cites this paper
• HSPA5 promotes YAP/TAZ stability independently of the Hippo pathway and induces proneural-to-mesenchymal transition in glioblastoma

  2026cites this paper
• Signaling pathways and targeted interventions for precancers

  2026cites this paper
• CLIM-TIME identifies metastatic microenvironment modulators for T cell therapy response.

  2026cites this paper
• Targeting super-enhancer-driven SKIL transcription by CDK7 inhibitor THZ1 to suppress gastric cancer progression

  2026cites this paper
• Decoding the Mutational Hierarchy of Thyroid Cancer and Associated Signaling Pathways.

  2026cites this paper
• WWP2 promotes the proliferation and metastasis of NSCLC through Hippo pathway and Wnt pathway

  2026cites this paper
• GRAFT: a graph-aware fusion transformer for cancer driver gene prediction

  2026cites this paper
• The mechanosensitive protein Zyxin influences Hippo signalling and tissue growth via adherens junctions and basal spot junctions in Drosophila

  2026cites this paper
• The oncogenic potential of YAP requires Y357 phosphorylation in cholangiocytes but not in hepatocytes

  2025cites this paper
• Hippo signaling pathway in cervical cancer: insights into mechanisms and therapeutic potential

  2025cites this paper
• Molecular Implications of ADIPOQ, GAS5, GATA4, and YAP1 Methylation in Triple-Negative Breast Cancer Prognosis

  2025cites this paper
• ATRX Loss Predicts Poor Outcomes and Reveals a Therapeutic Vulnerability to TEAD Inhibition in Soft Tissue Sarcomas

  2025cites this paper
• Primary cilia function as hubs for signal transduction

  2025cites this paper
• Phosphatase PPP1CC Regulates the First Lineage Segregation by GAS5 in Mouse Preimplantation Embryos.

  2025cites this paper
• Targeting ubiquitination in disease and therapy

  2025cites this paper
• A Novel Drosophila Model of Cancer Cachexia Reveals Conserved Jak/Stat Dependent Glucagon-like Akh Activation as a Driver of Metabolic Reprogramming and Systemic Wasting

  2025cites this paper
• Methylation-induced suppression of YAP/TAZ confers sensitivity to HDAC inhibitors in high-grade IDH mutant gliomas

  2025cites this paper
• Discovery of repurposed ethacrynic acid and its derivatives as novel TEAD inhibitors.

  2025cites this paper
• Inhibition of Hippo Signaling Through Ablation of Lats1 and Lats2 Protects Against Cognitive Decline in 5xFAD Mice via Increasing Neuronal Resilience Against Ferroptosis

  2025cites this paper
• Calcium ion-binding genes can predict tumor mutation burden and immune checkpoint blockade response in a pan-cancer model

  2025cites this paper
• Identification of pyrazolo-piperidinone derivatives targeting YAP-TEAD interface 3 as anticancer agents through integrated virtual screening and mass spectrometry proteomics.

  2025cites this paper
• Casein kinase 1 family member CSNK1E can regulate proliferation and migration in hepatocellular carcinoma

  2025cites this paper
• Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma models

  2025cites this paper
• Podocyte YAP and TAZ hyperactivation drives glomerular epithelial proliferative diseases in mice and humans.

  2025cites this paper
• Epithelial‐Mesenchymal Plasticity in the D‐Meso‐Sonobe Mesothelioma Cell Line: A Putative Model of Epithelial–Mesenchymal Transition in Mesothelioma

  2025cites this paper
• TET2 orchestrates YAP signaling to potentiate targetable vulnerability in hepatocellular carcinoma

  2025cites this paper
• The modes of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR) and the peroxisome proliferator-activated receptor alpha (PPARα) are not relevant to human cancer risk: an updated critical evaluation

  2025cites this paper
• YAP/TAZ activity in PDGFRα-expressing alveolar fibroblasts modulates AT2 proliferation through Wnt4.

  2025cites this paper
• HÜCRE DIŞI MATRİS VE MEKANOTRANSDÜKSİYONUN KANSER ÜZERİNDEKİ ETKİLERİ

  2025cites this paper
• MITF maintains genome stability in non-melanocytic cell lineages and suppresses Hippo pathway signaling

  2025cites this paper
• YAP maintains the dynamics of TDP-43 condensates and antagonizes TDP-43 pathological aggregates

  2025cites this paper
• Hippo/YAP signaling’s multifaceted crosstalk in cancer

  2025cites this paper
• Discovery and Optimization of LATS1 and LATS2 Kinase Inhibitors for Use in Regenerative Medicine

  2025cites this paper
• Targeting the Hippo/YAP Pathway: A Promising Approach for Cancer Therapy and Beyond

  2025cites this paper
• Endogenous YAP/TAZ partitioning in TEAD condensates orchestrates the Hippo response.

  2025cites this paper
• Mutant RIT1 cooperates with YAP to drive an EMT-like lung cancer state

  2025cites this paper
• Overexpressed miR-135b in the ovaries of PCOS promotes granulosa cell proliferation by inhibiting Hippo signaling pathway

  2025cites this paper
• A Novel Zinc(II) Complex for Sonodynamic Therapy Induces Pyroptosis of Breast Cancer Cells and Enhances Anti‐Tumor Immune Response

  2025cites this paper
• Mutation profile and molecular heterogeneity in mismatch repair deficient endometrial carcinoma

  2025cites this paper
• A computational approach reveals the critical role of PARK2 gene and the potential infectious pathways and HPV infection in colorectal cancer

  2025cites this paper
• Burkitt's Lymphoma and Early B Cell Transformation as Paradigms of How Epstein-Barr Virus Overcomes Apoptosis and Ferroptosis.

  2025cites this paper
• Genome-wide CRISPR screen identifies ALG5, ALG6, NF2, and FUT8 as key host proteins involved in transmissible gastroenteritis virus infection.

  2025cites this paper
• Mechanism of ECM Stiffness-Integrin-Hippo-ABCG1 axis in regulating ferroptosis and targeted nanodrug intervention in LUAD

  2025cites this paper
• Mechanosensor YAP orchestrates human neural rosette morphogenesis via TEAD4-LEF1 transcriptional nexus

  2025cites this paper
• TEAD4-siRNA as an Emerging Drug for the Treatment of Gastric Cancer

  2025cites this paper
• Progress in Prevention and Treatment of Breast Cancer by Traditional Chinese Medicine Targeting Hippo Signaling Pathway

  2025cites this paper
• Dynamic and selective competition governs binding of large tumor suppressor 1 to KIBRA and YAP

  2025cites this paper
• SCORT–Cas13d Nanotherapy Precisely Targets the ‘Undruggable’ Transcription Factor HoxB13 in Metastatic Prostate Cancer In Vivo

  2025cites this paper
• Targeting the Hippo Pathway in Breast Cancer: A Proteomic Analysis of Yes-Associated Protein Inhibition

  2025cites this paper
• Cell Confluency Affects p53 Dynamics in Response to DNA Damage.

  2025cites this paper
• Immunohistochemical Expression of PARK2 and YAP in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma

  2025cites this paper
• Integration of focal adhesion morphogenesis and polarity by DOCK5 promotes YAP/TAZ-driven drug resistance in TNBC

  2025cites this paper
• Targeting the Hippo pathway in cancer

  2025influential citation
• Exploring the mechanism of baicalein on breast cancer based on network pharmacology, molecular docking and in vivo experiments.

  2025cites this paper
• TEAD inhibition alters the lung immune microenvironment and attenuates metastasis

  2025cites this paper
• Hippo signalling regulates the nuclear behaviour and DNA dwell times of YAP and TEAD to control transcription

  2025cites this paper
• Advances in Palmitoylation: A key Regulator of liver cancer development and therapeutic targets.

  2025cites this paper
• Cooperation between the Hippo and MAPK pathway activation drives acquired resistance to TEAD inhibition

  2025cites this paper
• Yes-associated protein plays oncogenic roles in human sporadic colorectal adenomas

  2025cites this paper
• Anticancer and cancer preventive activities of shogaol and curcumin from Zingiberaceae family plants in KG-1a leukemic stem cells

  2025cites this paper
• Health benefits of physical activity: What role does skeletal muscle-organ crosstalk play?

  2025cites this paper
• Decoding driver and phenotypic genes in cancer: Unveiling the essence behind the phenomenon.

  2025cites this paper
• Upstream transcription factor 1 suppresses laryngeal squamous cell carcinoma progression through transcriptional activation of junctional adhesion molecule 3

  2025cites this paper
• Targeting the disrupted Hippo signaling to prevent neoplastic renal epithelial cell immune evasion

  2025cites this paper
• Hippo-YAP pathway regulates antimicrobial immune response in obscure puffer Takifugu obscurus.

  2025cites this paper
• Hyperactivated YAP1 is essential for sustainable progression of renal clear cell carcinoma

  2025cites this paper
• Moxidectin unravels the role of Hippo-YAP pathway in maintaining immunity of glioblastoma multiforme.

  2025cites this paper
• USP24 promotes hepatocellular carcinoma progression by deubiquitinating and stabilizing YAP1

  2025cites this paper
• Xihuang Pill Suppressed Primary Liver Cancer Growth by Downregulation of AFP and YAP Signaling.

  2025cites this paper
• YAP Expression is Related to the Aggressive Behavior of Odontogenic Cysts

  2025cites this paper
• TEAD1 condensates are transcriptionally inactive storage sites on the pericentromeric heterochromatin

  2025cites this paper
• The N-terminus of the Chlamydia trachomatis effector Tarp engages the host Hippo pathway

  2025cites this paper
• SEgene identifies links between super enhancers and gene expression across cell types

  2025cites this paper
• Deep-learning-enabled multi-omics analyses for prediction of future metastasis in cancer

  2025cites this paper
• Regulatory Mechanism of Intestinal Stem Cells Based on Hippo Pathway and Signaling Crosstalk in Chicken

  2025cites this paper
• Exploring hiPSC-CM replacement therapy in ischemic hearts

  2025cites this paper
• Multiple signaling pathways in the frontiers of lung cancer progression

  2025cites this paper
• An integrated proteomic portrait of prostate cancer progression.

  2025cites this paper
• Tumour Cell Size Control and Its Impact on Tumour Cell Function

  2025cites this paper
• Metastatic tumor growth in steatotic liver is promoted by HAS2-mediated fibrotic tumor microenvironment

  2025cites this paper
• Hippo signaling regulates the nuclear behavior and DNA binding times of YAP and TEAD to control transcription

  2025cites this paper
• Pharmacological targeting of large tumor suppressor kinases (LATS) 1 and 2 augments tissue repair and regeneration

  2025cites this paper
• Tumor cell-intrinsic stress states drive sensitivity to CAR T cell-therapy in pancreatic cancer

  2025cites this paper
• A feedforward loop between STAT1 and YAP1 stimulates lipid biosynthesis, accelerates tumor growth, and promotes chemotherapy resistance in mutant KRAS colorectal cancer

  2025cites this paper
• Neuroprotective role of Hippo signaling by microtubule stability control in Caenorhabditis elegans

  2025cites this paper